Nature Rev Immunol
@NatRevImmunol
Followers
69K
Following
2K
Media
1K
Statuses
6K
We publish immunology reviews. Tweets from the editors: Alex, Kirsty, Lucy & Yvonne. Find us here too: https://t.co/IrscA6xKVA
London, UK
Joined February 2011
You can now request a free copy of the poster from our sponsor @STEMCELLTech using the following link:
Rational combination of cancer therapies with PD1 axis blockade.New poster by @d_peeper & @ThommenDaniela with our pals @NatureRevCancer looking at how therapies can be combined in a rational manner to provide cooperative or synergistic benefit
0
2
13
Mechanisms of antibody-dependent enhancement of infectious disease
1
83
235
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
8
522
912
The roles of extracellular vesicles in the immune system
3
205
747
The trinity of COVID-19: immunity, inflammation and intervention
3
404
701
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
7
249
643
NEW Review: The roles of extracellular vesicles in the immune system.by @EditBuzas @semmelweishu.including roles of #EVs in innate and adaptive immunity, and potential use for diagnosis and therapy.#extracellularvesicles #exosomes
4
184
600
Location matters: mapping antigen receptors within tissues
0
69
277
'A guide to vaccinology: from basic principles to new developments'.Andrew Pollard & Else Bijker @UniofOxford @OxfordVacGroup ."an introductory overview of vaccines, immunization and related issues to inform a broad scientific audience" #VaccinesWork
2
241
464
The effect of physical exercise on anticancer immunity
1
172
449
Engineering IL-2 for immunotherapy of autoimmunity and cancer
3
89
439
Fibroblasts as immune regulators in infection, inflammation and cancer
3
121
439
Immunomodulation by endothelial cells — partnering up with the immune system?
4
126
428
New immune cell engagers for cancer immunotherapy
1
140
427
Ultra-processed foods: increasing the risk of inflammation and immune dysregulation?
2
149
418
COVID-19 vaccines: modes of immune activation and future challenges
3
159
392
The OrganiX microfluidic system to recreate the complex tumour microenvironment
1
87
358
Rational combination of cancer therapies with PD1 axis blockade.New poster by @d_peeper & @ThommenDaniela with our pals @NatureRevCancer looking at how therapies can be combined in a rational manner to provide cooperative or synergistic benefit
0
8
65
New: Our current understanding of the immunology behind #LongCovid, a comprehensive Review by @Daltmann10, Emily M. Whetlock, Siyi Liu, Deepa J. Arachchillage and @BoytonRosemary.
7
187
364
NEW Review: A guide to adaptive immune memory.by @DonnaFarber3 @noralam_ & YoonSeung Lee.provides an overview of current understanding of the phenotype, function, location, generation, maintenance and protective capacity of memory T cells and B cells
0
106
369
How the immune system shapes atherosclerosis: roles of innate and adaptive immunity
1
100
356
Same yet different — how lymph node heterogeneity affects immune responses
0
102
321
'The first 12 months of COVID-19: a timeline of immunological insights' by @VirusesImmunity @florian_krammer @CyrilPedia .details the collaborative efforts that enabled key aspects of the immune response to SARS-CoV-2 to be reported at unprecedented speed
5
133
317
Congratulations to James Allison and Tasuku Honjo #NobelPrize #cancer #immunotherapy Watch our movie (with @NatureRevCancer) to learn how immune checkpoint therapy works:
2
196
316
TGFβ control of immune responses in cancer: a holistic immuno-oncology perspective
1
83
324
The germinal centre B cell response to SARS-CoV-2
4
112
311
How bile acids and the microbiota interact to shape host immunity
1
95
323
Dissecting antibody-mediated protection against SARS-CoV-2
4
169
309
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy
3
96
310
Inflammasome activation at the crux of severe COVID-19
3
106
289
CD8+ T cell differentiation and dysfunction in cancer
0
70
287
The potential danger of suboptimal antibody responses in COVID-19
3
163
284
Rethinking peripheral T cell tolerance: checkpoints across a T cell’s journey
0
92
287
Regulation of immune responses by the airway epithelial cell landscape
0
84
282
Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?
1
93
284
@DrPragyaAgarwal Oh dear. Just as well a few women broke the rules and left home to make us a vaccine.
0
12
270
Inflammation and immune dysfunction in Parkinson disease
5
102
271
The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?
0
132
267
Human stem cell models to study host–virus interactions in the central nervous system
1
61
255
Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19
1
72
254
New Comment article from @VirusesImmunity and Yexin Yang on the potential danger of suboptimal antibody responses in COVID-19
4
146
250
NEW Comment article by @VikiLovesFACS @imperialcollege .'Are COVID-19 vaccines safe in pregnancy?'.
4
117
250
Trogocytosis challenges the cellular specificity of lineage markers and monoclonal antibodies
0
76
245
Redefining our vision: an updated guide to the ocular immune system
0
66
257
Bacterial origins of human cell-autonomous innate immune mechanisms
0
70
243
The role of platelets in immune-mediated inflammatory diseases
1
68
242
Role of the microbiota in response to and recovery from cancer therapy
0
102
235
New Review on how circadian rhythms influence the immune system. #circadian_clock.#chrono-immunotherapy
1
158
225
Glomerulonephritis: immunopathogenesis and immunotherapy
1
70
232
The precursors of CD8+ tissue resident memory T cells: from lymphoid organs to infected tissues
1
64
226
See new Progress article from Zeyu Chen and @EJohnWherry on T cell responses in patients with COVID-19
2
119
220
The cGAS–STING pathway as a therapeutic target in inflammatory diseases
0
58
218
Inflammasome components as new therapeutic targets in inflammatory disease
1
65
224
Red blood cells join the ranks as immune sentinels
4
80
217
The impact of the gut microbiome on extra-intestinal autoimmune diseases
0
66
215
Immunomodulation by radiotherapy in tumour control and normal tissue toxicity
1
55
209
Tumours tend to disseminate early, yet metastases often take years to maifest. What determines when and where they form? @alpcorreia discusses the site specific immune barriers to metastasis in this perspective
1
44
209
Is IL-6 a key cytokine target for therapy in COVID-19?
2
81
211
How transcription factors drive choice of the T cell fate
0
63
204
Our October 2021 issue marks 20 years of Nature Reviews Immunology - see our special anniversary collection:
6
90
204
Therapeutic induction of antigen-specific immune tolerance
2
55
189
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
7
74
205
The link between circulating follicular helper T cells and autoimmunity
2
54
200
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
1
53
201
Tumour immunotherapy: lessons from predator–prey theory
2
65
201
Immune and non-immune functions of adipose tissue leukocytes
3
41
201
IL-17 and IL-17-producing cells in protection versus pathology
1
56
196
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
1
80
198
Antigen presentation for central tolerance induction
1
55
194
Diversity and dynamism of IgA−microbiota interactions
1
54
181
See the new Comment from Schett et al. on COVID-19: risk for cytokine targeting in chronic inflammatory diseases?
1
118
182
Immune-based therapies in cardiovascular and metabolic diseases: past, present and future
1
54
180
Bone marrow inflammation in haematological malignancies
3
66
182
Thymic development of unconventional T cells: how NKT cells, MAIT cells and γδ T cells emerge
1
69
177
B cells, plasma cells and antibody repertoires in the tumour microenvironment
1
76
175
Integrated organ immunity: a path to a universal vaccine
0
59
182
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations
1
56
170